Saturday, November 07, 2015 7:01:46 PM
Gary E. Gilbert, MD
VA Boston Healthcare System, Harvard Medical School
Boston, MA
Platelet Phosphatidylserine Exposure, Survival and Blood Coagulation in Mice Lacking TMEM16F
Gary Gilbert.... I'm actually a bit surprised at this exposure into the VA Boston
----------------------------
Gary Gilbert
Principal Investigator at Research in blood coagulation, emphasizing membrane interface
Greater Boston Area
Research
Current
VA Boston Healthcare System, Harvard University, Research in blood coagulation, emphasizing membrane interface
Education
Tufts University
286
connections
Experience
Chief, Hematology and Oncology
VA Boston Healthcare System
2015 – Present (less than a year)VA Boston Healthcare System
Associate Prof of Medicine
Harvard University
2011 – Present (4 years)
Principal Investigator
Research in blood coagulation, emphasizing membrane interface
September 1989 – Present (26 years 3 months)VA Boston Healthcare System
My laboratory focuses on coagulation factor VIII and lactadherin a.k.a. mfg-e8. We are particularly interested in the manner in which chemical and physical changes of the membrane regulate coagulation activity of the blood
..
..
..
https://www.linkedin.com/pub/gary-gilbert/72/440/652
"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!
